1-4 of 4
Jorge A. Almenara
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cytokinetically quiescent (G 0 /G 1 ) human multiple myeloma cells are susceptible to simultaneous inhibition of Chk1 and MEK1/2

Xin-Yan Pei, Yun Dai, Leena E. Youssefian, Shuang Chen, Wesley W. Bodie, Yukie Takabatake, Jessica Felthousen, Jorge A. Almenara, Lora B. Kramer, Paul Dent, Steven Grant
Journal: Blood
Blood (2011) 118 (19): 5189–5200.
https://doi.org/10.1182/blood-2011-02-339432
Published: 2011
Includes: Supplemental data
Journal Articles

Disruption of Src function potentiates Chk1-inhibitor–induced apoptosis in human multiple myeloma cells in vitro and in vivo

Yun Dai, Shuang Chen, Rena Shah, Xin-Yan Pei, Li Wang, Jorge A. Almenara, Lora B. Kramer, Paul Dent, Steven Grant
Journal: Blood
Blood (2011) 117 (6): 1947–1957.
https://doi.org/10.1182/blood-2010-06-291146
Published: 2011
Includes: Supplemental data
Journal Articles

Interruption of the Ras/MEK/ERK signaling cascade enhances Chk1 inhibitor–induced DNA damage in vitro and in vivo in human multiple myeloma cells

Yun Dai, Shuang Chen, Xin-Yan Pei, Jorge A. Almenara, Lora B. Kramer, Charis A. Venditti, Paul Dent, Steven Grant
Journal: Blood
Blood (2008) 112 (6): 2439–2449.
https://doi.org/10.1182/blood-2008-05-159392
Published: 2008
Includes: Supplemental data
Journal Articles

A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia

Steven W. Paugh, Barbara S. Paugh, Mohamed Rahmani, Dmitri Kapitonov, Jorge A. Almenara, Tomasz Kordula, Sheldon Milstien, Jeffrey K. Adams, Robert E. Zipkin, Steven Grant, Sarah Spiegel
Journal: Blood
Blood (2008) 112 (4): 1382–1391.
https://doi.org/10.1182/blood-2008-02-138958
Published: 2008